Business - Briefly   

Natco launches new drug

HYDERABAD: Natco Pharma has launched Ibandronate Sodium in tablet and injection forms in the markets. Carrying the brand name Bandrone, the new drug is meant for use in the treatment of metastatic bone disease and elevated serum and calcium levels in tumours.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

IBM to invest $6 billion
Sensex plunges below 10000
India may scale down offer on services
Vision to boost leather exports three-fold
Panacea to commercialise IVRI tech
Tata Tea achieves record profit based on strong brand sales
Land size issue of Special Economic Zones resolved
Posco to employ 7,000
Rupee loses 14 paise
Exchange rates
Bullion rates
Views on Cable TV Act amendments sought
Natco launches new drug
Damodaran is IOSCO panel Chairman
LG hikes refrigerator prices
U.K. clamps down on PSE wage costs
TimesofMoney launches e-Wallet
MCX and NYMEX forge licensing agreement
Ace Micromatic group's plans
IOB hikes interest rates on term deposits
Bharat Overseas Bank hikes deposit rates
TMB increases NRE, FCNR (B) rates
Railways bags IT implementation award

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu